E-LIB Suche - Ergebnisse für: See, W.A

1

P498: CLINICAL AND BIOLOGICAL MARKERS ASSOCIATED WITH LONG-..:

Wei, A. H. ; Döhner, H. ; Sayar, H....
HemaSphere. 6 (2022) - p. 397-398 , 2022

2

Safety and Feasibility Of Dose Escalated Pelvic Lymph Node ..:

Hall, W.A. ; Bedi, M. ; Kilari, D....
International Journal of Radiation Oncology*Biology*Physics. 105 (2019) 1 - p. E277-E278 , 2019

Link: https://doi.org/10.1016/..

3

Stat5 mediates enzalutamide-resistant prostate cancer growt:

Nevalainen, M. ; Udhane, V. ; Maranto, C....
European Urology Supplements. 18 (2019) 1 - p. e1337 , 2019

Link: https://doi.org/10.1016/..

4

Positive status for STAT5 locus amplification in conjunctio..:

Nevalainen, M. ; Haddad, B. ; Erickson, A.M....
European Urology Supplements. 17 (2018) 2 - p. e151-e152 , 2018

Link: https://doi.org/10.1016/..

5

Prognostic Value of Clinical Stage T2 Substages in Prostate..:

Borkenhagen, J. ; Eastwood, D. ; Kilari, D....
International Journal of Radiation Oncology*Biology*Physics. 99 (2017) 2 - p. E216-E217 , 2017

Link: https://doi.org/10.1016/..

6

Androgen Deprivation Therapy (ADT) and Radiation Therapy (R..:

Hall, W.A. ; Eastwood, D. ; Kilari, D....
International Journal of Radiation Oncology*Biology*Physics. 99 (2017) 2 - p. S7-S8 , 2017

Link: https://doi.org/10.1016/..

7

TH-AB-209-09: Quantitative Imaging of Electrical Conductivi..:

Patch, S ; Hull, D ; See, W.
Medical Physics. 43 (2016) 6Part44 - p. 3865-3865 , 2016

Link: https://doi.org/10.1118/..

8

The Quistclose Trust in Singapore:

See, A. W.- L.
Trusts & Trustees. 20 (2014) 4 - p. 362-372 , 2014

Link: https://doi.org/10.1093/..

9

DN-03 * MUTANT IDH1-DRIVEN CELLULAR TRANSFORMATION INCREASE..:

Ohba, S. ; Mukherjee, J. ; See, W..
Neuro-Oncology. 16 (2014) suppl 5 - p. v62-v62 , 2014

Link: https://doi.org/10.1093/..

10

Toxicities and Survival of Elderly Patients With Muscle-Inv..:

Lindsay, D.P. ; Kharofa, J.R. ; Lawton, C.A....
International Journal of Radiation Oncology*Biology*Physics. 87 (2013) 2 - p. S398 , 2013

Link: https://doi.org/10.1016/..

11

Bicalutamide 150 mg in Addition to Standard Care Delays Pro..:

See, W. ; McLeod, D.G. ; Wirth, M.P....
International Journal of Radiation Oncology*Biology*Physics. 63 (2005) - p. S286-S287 , 2005

Link: https://doi.org/10.1016/..

12

180 Bicalutamide ('Casodex') 150 mg in addition to watchful..:

Iversen, P. ; McLeod, D. ; See, W....
European Urology Supplements. 3 (2004) 2 - p. 47 , 2004

Link: https://doi.org/10.1016/..

13

Reply to A. Tubaro and C. De Nunzio:

See, W. ; Iversen, P. ; Wirth, M...
European Urology. 45 (2004) 5 - p. 674-675 , 2004

Link: https://doi.org/10.1016/..

14

224 Response to second-line hormonal therapy following prog..:

Wirth, M. ; Iversen, P. ; McLeod, D....
European Urology Supplements. 3 (2004) 2 - p. 58 , 2004

Link: https://doi.org/10.1016/..

15

181 Bicalutamide ('Casodex') 150 mg as adjuvant to radical ..:

Wirth, M. ; Iversen, P. ; McLeod, D....
European Urology Supplements. 3 (2004) 2 - p. 48 , 2004

Link: https://doi.org/10.1016/..